Ticker Details
ABBVIE INC. AbbVie Inc is a biopharmaceutical company that discovers, develops, manufactures and sells a range of pharmaceutical products for treating chronic autoimmune diseases, virology and neurological disorders.
IPO Date:	December 14, 2012
Sector:	Healthcare
Industry:	Drug Manufacturers
Market Cap:	$397.33B
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$1.04 | 1.02%
Avg Daily Range (30 D):	$2.61 | 1.18%
Avg Daily Range (90 D):	$2.41 | 1.07%

Institutional Daily Volume
Avg Daily Volume:	6.21M
Avg Daily Volume (30 D):	5.26M
Avg Daily Volume (90 D):	4.42M

Trade Size
Avg Trade Size (Sh.):	104
Avg Trade Size (Sh.) (30 D):	57
Avg Trade Size (Sh.) (90 D):	52

Institutional Trades
Total Institutional Trades:	63,678
Avg Institutional Trade:	$10.44M
Avg Institutional Trade (30 D):	$23.97M
Avg Institutional Trade (90 D):	$28.17M
Avg Institutional Trade Volume:	.1M
Avg Institutional Trades (Per Day):	19

Market Closing Trades
Avg Closing Trade:	$89.84M
Avg Closing Trade (30 D):	$291.36M
Avg Closing Trade (90 D):	$269.94M
Avg Closing Volume:	779.21K

News

Feb 20, 2026 @ 1:02 PM FDA Approval For AbbVie/AstraZeneca's Combination ... Source: Vandana Singh

Feb 19, 2026 @ 2:37 PM AbbVie Declares Quarterly Dividend Source: Prnewswire

Feb 18, 2026 @ 12:00 PM Alzheimer's Therapeutics Market Research Report 20... Source: Researchandmarkets.Com

Feb 16, 2026 @ 1:00 PM Uterine Fibroid Market Size to Reach USD 9.43 Bill... Source: Sns Insider Research

Feb 16, 2026 @ 11:00 AM Lip Augmentation Market Size to Reach USD 17.37 Bi... Source: Sns Insider Research

Financials
	TTM	Q4 2025	FY 2025
Basic EPS	$2.37	$1.02	$2.37
Diluted EPS	$2.36	$1.02	$2.36
Revenue	$61.16B	$16.62B	$61.16B
Gross Profit	$42.96B	$12.07B	$42.96B
Net Income / Loss	$4.23B	$1.82B	$4.23B
Operating Income / Loss	$15.08B	$4.54B	$15.08B
Cost of Revenue	$18.2B	$4.55B	$18.2B
Net Cash Flow	$-295M	$-400M	$-295M
PE Ratio	96.76